Ecarin chromogenic assay - A new method for quantitative determination of direct thrombin inhibitors like hirudin

Pathophysiology of Haemostasis and Thrombosis

Volumn 33, Issue 4, 2003, Pages 184-191

  Lange, U ^a,b   Nowak, G ^a   Bucha, E ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b HaemoSys Ltd   (Germany)

Author keywords

Argatroban; Ecarin chromogenic assay; Ecarin clotting time; Hirudin; Thrombin inhibitor

Indexed keywords

ARGATROBAN; CHROMOGENIC SUBSTRATE; FIBRINOGEN; HEPARIN; HIRUDIN; LEPIRUDIN; MEIZOTHROMBIN; PROTHROMBIN; THROMBIN INHIBITOR;

ACCURACY; ARTICLE; ASSAY; CALCULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MONITORING; ECARIN CHROMOGENIC ASSAY; HUMAN; INTERMETHOD COMPARISON; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS;

CHROMOGENIC COMPOUNDS; DRUG MONITORING; ENDOPEPTIDASES; ENZYME PRECURSORS; HIRUDINS; HUMANS; INDICATORS AND REAGENTS; METHODS; PIPECOLIC ACIDS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SERINE PROTEINASE INHIBITORS; THROMBIN;

EID: 10844269522     PISSN: 14248832     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081506     Document Type: Article

References (28)

1. Tripodi A, Chantarangkul V, Arbini AA, Moia M, Mannucci PM: Effects of hirudin on activated partial thromboplastin time determined with ten different reagents. Thromb Haemost 1993;70:286-288.
2. Nurmohamed MT, Berckmans RJ, Morrien-Salomons WM, Berends F, Hommes DW, Rijnierse JJ, Sturk A: Monitoring anticoagulant therapy by activated partial thromboplastin time: Hirudin assessment. An evaluation of native blood and plasma assays. Thromb Haemost 1994;72:685-692.
3. Cullberg M, Eriksson UG, Larsson M, Karlsson MO: Population modelling of the effect of inogatran, a thrombin inhibitor, on ex vivo coagulation time (APTT) in healthy subjects and in patients with coronary artery disease. Br J Clin Pharmacol 2001;51:71-79.
4. Despotis GJ, Hogue CW, Saleem R, Bigham M, Skubas N, Apostolidou I, Qayum A, Joist JH: The relationship between hirudin and activated clotting time: Implications for patients with heparin-induced thrombocytopenia undergoing cardiac surgery. Anesth Analg 2001;93:28-32.
5. Reid TJ 3rd, Alving BM: A quantitative thrombin time for determining levels of hirudin and hirulog. Thromb Haemost 1993;70:608-616.
6. Spinner S, Stoffler G, Fink E: Quantitative enzyme-linked immunosorbent assay (ELISA) for hirudin. J Immunol Methods 1986;87:79-83.
7. Spinner S, Scheffauer F, Maschler R, Stoffler G: A hirudin catching ELISA for quantitating the anticoagulant in biological fl uids. Thromb Res 1988;51:617-625.
8. Iyer L, Adam M, Amiral J, Fareed J, Bermes E Jr: Development and validation of two enzyme-linked immunosorbent assay (ELISA) methods for recombinant hirudin. Semin Thromb Hemost 1995;21:184-192.
9. Griessbach U, Stürzebecher J, Markwardt F: Assay of hirudin in plasma using a chromogenic thrombin substrate. Thromb Res 1985;37:347-350.
10. Stürzebecher J: Methods for determination of hirudin. Semin Thromb Hemost 1991;17:99-102.
11. Spannagl M, Bichler J, Birg A, Lill H, Schramm W: Development of a chromogenic substrate assay for the determination of hirudin in plasma. Blood Coagul Fibrinolysis 1991;2:121-127.
12. Groetsch H, Damm D, Ben Youssef R, Haertel D: Comparison of two different methods for the determination of rDNA-hirudin in plasma samples: HPLC vs a chromogenic thrombin substrate. Thromb Res 1991;64:273-277.
13. Hafner G, Fickenscher K, Friesen HJ, Rupprecht HJ, Konheiser U, Ehrenthal W, Lotz J, Prellwitz W: Evaluation of an automated chromogenic substrate assay for the rapid determination of hirudin in plasma. Thromb Res 1995;77:165-173.
14. Calatzis A, Spannagl M, Gempeler-Messina P, Kolde HJ, Schramm W, Haas S: The prothrombinase-induced clotting test: A new technique for the monitoring of anticoagulants. Haemostasis 2000;30(suppl 2):172-174.
15. Nowak G, Bucha E: A new method for the therapeutic monitoring of hirudin. Thromb Haemost 1993;69:306-310.
16. Nowak G: Monitoring of the action of antithrombin agents by ecarin clotting time; in Pifarré R (ed): New Anticoagulants for the Cardiovascular Patient. Philadelphia, Hanley & Belfus, 1997, pp 539-550.
17. Nowak G: Clinical monitoring of hirudin and direct thrombin inhibitors. Semin Thromb Hemost 2001;27:537-541.
18. Hafner G, Roser M, Nauck M: Methods for the monitoring of direct thrombin inhibitors. Semin Thromb Hemost 2002;28:425-430.
19. Ratnoff OD, Menzie C: A new method for the determination of fi brinogen in small samples of plasma. J Lab Clin Med 1954;37:316-320.
20. Nowak G, Bucha E: Quantitative determination of hirudin in blood and body fluids. Semin Thromb Hemost 1996;22:197-202.
21. Morita T, Iwanaga S, Suzuki T: The mechanism of action of bovine prothrombin by an activator isolated from Echis carinatus venom and characterization of the new active intermediates. J Biochem (Tokyo) 1976;79:1089-1108.
22. Rhee MJ, Morris S, Kosow DP: Role of meizothrombin and meizothrombin-(des F1) in the conversion of prothrombin to thrombin by the Echis carinatus venom coagulant. Biochemistry 1982;21:3437-3443.
23. Cote HC, Stevens WK, Bajzar L, Banfield DK, Nesheim ME, MacGillivray RT: Characterization of a stable form of human meizothrombin derived from recombinant prothrombin (R155A, R271A, and R284A). J Biol Chem 1994;269:11374-11380.
24. Schoen P, Lindhout T: The in situ inhibition of prothrombinase-formed human alphathrombin and meizothrombin (des F1) by antithrombin III and heparin. J Biol Chem 1987;262:11268-11274.
25. Lindhoff-Last E, Piechottka GP, Rabe F, Bauersachs R: Hirudin determination in plasma can be strongly infl uenced by the prothrombin level. Thromb Res 2000;100:55-60.
26. Lange U, Wiesenburg A, Olschewski A, Nowak G, Bucha E: Quantitative determination of direct thrombin inhibitors using the ecarin chromogenic assay (ECA) - both POCT and automated method. Ann Hematol 2003;82(suppl 1):S53.
27. Kathiresan S, Shiomura J, Jang IK: Argatroban. J Thromb Thrombolysis 2002;13:41-47.
28. Fenyvesi T, Jörg I, Harenberg J: Monitoring of anticoagulant effects of direct thrombin inhibitors. Semin Thromb Hemost 2002;28:361-368.